Inspire Medical Systems, Inc.
INSPNYSECIK 1609550HealthcareFiscal year ends Dec 31
Reports and events: 147 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0316:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001609550-26-000047 |
| 2026-08-0316:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-26-000045 |
| 2026-07-2416:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001609550-26-000041 |
| 2026-07-2208:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001609550-26-000038 |
| 2026-06-2606:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-26-000035 |
| 2026-05-0516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001609550-26-000026 |
| 2026-05-0416:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001609550-26-000023 |
| 2026-05-0416:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-26-000021 |
| 2026-03-2007:51 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001140361-26-010490 |
| 2026-02-1316:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001609550-26-000016 |
| 2026-02-1116:32 ET | 8-K | 2.02 Results of operations; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-26-000012 |
| 2026-01-1217:04 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-26-000006 |
| 2025-11-1716:36 ET | 8-K | 8.01 Other events | 0001609550-25-000055 |
| 2025-11-0316:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001609550-25-000053 |
| 2025-11-0316:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000052 |
| 2025-10-1006:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000046 |
| 2025-08-2617:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000040 |
| 2025-08-1116:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001609550-25-000035 |
| 2025-08-0416:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001609550-25-000032 |
| 2025-08-0416:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000030 |
| 2025-06-1306:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000025 |
| 2025-05-0516:27 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001609550-25-000020 |
| 2025-05-0516:11 ET | 8-K | 5.07 Shareholder vote results | 0001609550-25-000019 |
| 2025-05-0516:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000018 |
| 2025-03-1816:05 ET | DEF 14A | Proxy statementPeriod 2025-05-01 | 0001140361-25-009249 |
| 2025-02-1016:23 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001609550-25-000011 |
| 2025-02-1016:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000009 |
| 2025-01-1306:48 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000003 |
| 2024-11-1206:30 ET | 8-K | 8.01 Other events | 0001609550-24-000055 |
| 2024-11-0416:18 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001609550-24-000053 |
| 2024-11-0416:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-24-000050 |
| 2024-08-0616:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001609550-24-000044 |
| 2024-08-0616:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001609550-24-000042 |
| 2024-08-0208:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001609550-24-000036 |
| 2024-07-2906:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001609550-24-000034 |
| 2024-07-2217:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001609550-24-000032 |
| 2024-05-0716:43 ET | 8-K | 5.07 Shareholder vote results | 0001609550-24-000028 |
| 2024-05-0716:07 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001609550-24-000026 |
| 2024-05-0716:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-24-000024 |
| 2024-03-1916:31 ET | DEF 14A | Proxy statementPeriod 2024-05-02 | 0001140361-24-014155 |
| 2024-02-0916:02 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001609550-24-000016 |
| 2024-02-0616:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-24-000013 |
| 2024-02-0516:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001609550-24-000011 |
| 2024-01-2616:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001609550-24-000008 |
| 2024-01-0808:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-24-000004 |
| 2023-12-2808:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-129879 |
| 2023-11-0716:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-23-000065 |
| 2023-11-0716:27 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001609550-23-000063 |
| 2023-11-0716:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001609550-23-000061 |
| 2023-08-0116:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-23-000054 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:56 ET. Listed shows no prices and gives no investment advice.